Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis
NCT ID: NCT03326089
Last Updated: 2023-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2017-06-01
2023-08-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Effects of Oxygen Supplementation Among IPF Patients
NCT03688334
Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis
NCT03222648
Home Pulmonary Rehabilitation for COPD
NCT03480386
Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPD
NCT04257630
Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
NCT01107028
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High flow oxygen supplementation
Pulmonary rehabilitation with constant high flow supplementary oxygen supply FiO2 50% for 2 months (Group A).
Pulmonary rehabilitation
Endurance training for 30 minutes, 3 times/week for 2 months followed by resistance training
Oxygen supplementation upon hypoxemia
Pulmonary rehabilitation without oxygen supply unless upon resting or exercise induced hypoxemia for 2 months (Group B).
Pulmonary rehabilitation
Endurance training for 30 minutes, 3 times/week for 2 months followed by resistance training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulmonary rehabilitation
Endurance training for 30 minutes, 3 times/week for 2 months followed by resistance training
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no exacerbation previous 3 months
* no participation in such program previous 3 months.
* If on treatment with pirfenidone or nintedanib, this will be recorded and patient should be on treatment for at least 3-6 months to achieve stable state.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Corfu General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ilias Papanikolaou
Consultant Pulmonary Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefanos Patsiris
Role: STUDY_DIRECTOR
Physiotherapy Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Corfu General Hospital
Corfu, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CorfuGH569
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.